Use of extracorporeal membrane oxygenation in adults.

Since the first successful application of the heart-lung machine in 1953 by John Gibbon [1], great efforts have been made to modify the bypass techniques and devices in order to allow prolonged extracorporeal circulation in the intensive care unit (ICU), commonly referred to as extracorporeal membrane oxygenation (ECMO). ECMO uses classic cardiopulmonary bypass technology to support circulation. It provides continuous, non-pulsatile cardiac output and extracorporeal oxygenation [2]. Veno-venous ECMO (VV ECMO) provides respiratory support, while veno-arterial ECMO (VA ECMO) provides cardio-respiratory support to patients with severe but potentially reversible cardiac or respiratory deterioration refractory to standard therapeutic modalities. ECMO is a temporary form of life support providing a prolonged biventricular circulatory and pulmonary support for patients experiencing both pulmonary and cardiac failure unresponsive to conventional therapy. Despite the advent of newer ventricular assist devices that are more suitable for long term support, ECMO is simple to establish, cost-effective to operate.

[1]  M. Senni,et al.  Reduction of Haemorrhagic Complications during Mechanically Assisted Circulation with the Use of a Multi-System Anticoagulation Protocol , 1995, The International journal of artificial organs.

[2]  A. Goldman,et al.  Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[3]  M. Stroud,et al.  Successful use of extracorporeal membrane oxygenation in severe necrotizing pneumonia caused by Staphylococcus aureus* , 2007, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[4]  Duncan Macrae,et al.  UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation , 1996, The Lancet.

[5]  J. Arnold,et al.  Impact of AMICAR on hemorrhagic complications of ECMO: a ten-year review. , 2003, Journal of pediatric surgery.

[6]  Michael Quintel,et al.  Extracorporeal membrane oxygenation , 2005, Current opinion in critical care.

[7]  N. Smedira,et al.  Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years. , 2001, The Journal of thoracic and cardiovascular surgery.

[8]  C. Festen,et al.  Surgical repair of congenital diaphragmatic hernia during extracorporeal membrane oxygenation: hemorrhagic complications and the effect of tranexamic acid. , 1997, Journal of pediatric surgery.

[9]  E. Spitznagel,et al.  Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations. , 1994, The Journal of thoracic and cardiovascular surgery.

[10]  C. Foroulis,et al.  A prospective, double-blind study on the efficacy of the bioline surface-heparinized extracorporeal perfusion circuit. , 2003, The Annals of thoracic surgery.

[11]  E. Fosse,et al.  Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. , 1997, The Annals of thoracic surgery.

[12]  P. Rycus,et al.  Extracorporeal Life Support Registry Report 2004 , 2005, ASAIO journal.

[13]  J. Beca,et al.  Extracorporeal membrane oxygenation for treating severe cardiac and respiratory disease in adults: Part 1--overview of extracorporeal membrane oxygenation. , 2009, Journal of cardiothoracic and vascular anesthesia.

[14]  R. Bartlett,et al.  Significant safety advantages gained with an improved pressure-regulated blood pump. , 1996, The journal of extra-corporeal technology.

[15]  N. Smedira,et al.  Mechanical circulatory assistance: state of art. , 2002, Circulation.

[16]  M. Adams,et al.  Veno-arterial extracorporeal membrane oxygenation for high-risk cardiac catheterisation procedures. , 2010, Heart, lung & circulation.

[17]  S. Marasco,et al.  Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients. , 2008, Heart, lung & circulation.

[18]  T. Motomura,et al.  Development of silicone rubber hollow fiber membrane oxygenator for ECMO. , 2003, Artificial organs.

[19]  P. Betit Extracorporeal membrane oxygenation: quo vadis? , 2009, Respiratory care.

[20]  R. Hetzer,et al.  Successful use of bivalirudin as anticoagulant for ECMO in a patient with acute HIT. , 2007, The Annals of thoracic surgery.

[21]  J. Hirsh,et al.  Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. , 1992, Chest.

[22]  W. Oliver Anticoagulation and Coagulation Management for ECMO , 2009, Seminars in cardiothoracic and vascular anesthesia.

[23]  G. Patterson,et al.  Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. , 2002, The Journal of thoracic and cardiovascular surgery.

[24]  E. Fosse,et al.  Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. , 1992, The Journal of thoracic and cardiovascular surgery.

[25]  D. Cohn,et al.  Analysis of microembolic particles originating in extracorporeal circuits , 1987 .

[26]  A. Pesenti,et al.  Extracorporeal carbon dioxide removal (ECCO2R): a new form of respiratory assistance. , 1979, The International journal of artificial organs.

[27]  Peter Kleine,et al.  Venoarterial extracorporeal membrane oxygenation for treatment of cardiogenic shock: clinical experiences in 45 adult patients. , 2008, The Journal of thoracic and cardiovascular surgery.

[28]  J. Fortenberry,et al.  Primary use of the venovenous approach for extracorporeal membrane oxygenation in pediatric acute respiratory failure* , 2003, Pediatric Critical Care Medicine.

[29]  G. Gravlee,et al.  Cardiopulmonary Bypass: Principles and Practice , 2000 .

[30]  G. Nuttall,et al.  Efficacy of a Simple Intraoperative Transfusion Algorithm for Nonerythrocyte Component Utilization after Cardiopulmonary Bypass , 2001, Anesthesiology.

[31]  W. Ko,et al.  Extracorporeal membrane oxygenation support for adult postcardiotomy cardiogenic shock. , 2002, The Annals of thoracic surgery.

[32]  Vivek Trikha,et al.  Clinical Study , 1961, Acta neurologica Scandinavica.

[33]  E. Fosse,et al.  Differences in blood activation related to roller/centrifugal pumps and heparin coated/uncoated surfaces in a cardiopulmonary bypass model circuit , 1996, Perfusion.

[34]  K. Mellgren,et al.  Induced cell trauma during in vitro perfusion: a comparison between two different perfusion systems. , 1998, Artificial organs.

[35]  A. Ündar,et al.  Use of a Novel Anticoagulation Strategy During ECMO in a Pediatric Population: Single-Center Experience. , 2006, ASAIO journal.

[36]  R. Bartlett,et al.  Nosocomial infections in adult patients undergoing extracorporeal membrane oxygenation. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  Rolf Rossaint,et al.  Extracorporeal gas exchange with the DeltaStream rotary blood pump in experimental lung injury. , 2003, Artificial organs.

[38]  R. Bartlett,et al.  A toroidal flow membrane oxygenator: four day partial bypass in dogs. , 1969, Surgical forum.

[39]  T. Boes,et al.  Treatment of severe acute respiratory distress syndrome: role of extracorporeal gas exchange , 2006, Intensive Care Medicine.

[40]  N. Chi,et al.  Analysis of the outcome for patients experiencing myocardial infarction and cardiopulmonary resuscitation refractory to conventional therapies necessitating extracorporeal life support rescue* , 2006, Critical care medicine.

[41]  Takaaki Suzuki Additional lung-protective perfusion techniques during cardiopulmonary bypass. , 2010, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[42]  N. Doll,et al.  Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. , 2010, The Journal of thoracic and cardiovascular surgery.

[43]  J. Tobis,et al.  Subacute stent thrombosis associated with a heparin‐coated stent and heparin‐induced thrombocytopenia , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[44]  S. Renolleau,et al.  Venovenous single lumen cannula extracorporeal lung support in neonates. A five year experience. , 1993, ASAIO journal (1992).

[45]  J J Osborn,et al.  Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung. , 1972, The New England journal of medicine.

[46]  M. Gruber,et al.  In Vivo Uptake and Elimination of Isoflurane by Different Membrane Oxygenators during Cardiopulmonary Bypass , 2002, Anesthesiology.

[47]  J. Svennevig,et al.  Evaluation of oxygenators and centrifugal pumps for long-term pediatric extracorporeal membrane oxygenation , 2007, Perfusion.

[48]  X. Hou,et al.  Early and intermediate results of rescue extracorporeal membrane oxygenation in adult cardiogenic shock. , 2009, The Annals of thoracic surgery.

[49]  E. Spitznagel,et al.  More Effective Suppression of Hemostatic System Activation in Patients Undergoing Cardiac Surgery by Heparin Dosing Based on Heparin Blood Concentrations rather than ACT , 1996, Thrombosis and Haemostasis.

[50]  Pearson Dt Gas exchange: bubble and membrane oxygenators. , 1990, Seminars in thoracic and cardiovascular surgery.

[51]  J. Dhainaut,et al.  Effects of aprotinin on hemorrhagic complications in ARDS patients during prolonged extracorporeal CO2 removal , 2005, Intensive Care Medicine.

[52]  R. Bartlett,et al.  A prospective comparison of atrio-femoral and femoro-atrial flow in adult venovenous extracorporeal life support. , 1998, The Journal of thoracic and cardiovascular surgery.

[53]  G. Peek,et al.  Early Experience with a Polymethyl Pentene Oxygenator for Adult Extracorporeal Life Support , 2002, ASAIO journal.

[54]  A. Sosnowski,et al.  Poly-Methyl Pentene Oxygenators Have Improved Gas Exchange Capability and Reduced Transfusion Requirements in Adult Extracorporeal Membrane Oxygenation , 2005, ASAIO journal.

[55]  G Wright,et al.  Mechanical simulation of cardiac function by means of pulsatile blood pumps. , 1997, Journal of cardiothoracic and vascular anesthesia.

[56]  A. Vuylsteke,et al.  Successful extracorporeal membrane oxygenation support after pulmonary thromboendarterectomy. , 2008, The Annals of thoracic surgery.

[57]  R. Bartlett,et al.  Blood activation during neonatal extracorporeal life support , 1993 .

[58]  D. S. Lawson,et al.  North American neonatal extracorporeal membrane oxygenation (ECMO) devices: 2002 survey results. , 2004, The journal of extra-corporeal technology.

[59]  N. Doll,et al.  Autopsy Findings in Patients on Postcardiotomy Extracorporeal Membrane Oxygenation (ECMO) , 2006, The International journal of artificial organs.

[60]  J. O'Neill,et al.  Nosocomial infections during extracorporeal membrane oxygenation , 2001, Intensive Care Medicine.

[61]  Robert H. Bartlett,et al.  Extracorporeal Life Support for Severe Acute Respiratory Distress Syndrome in Adults , 2004, Annals of surgery.

[62]  Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. , 1979 .

[63]  C. Tribble,et al.  When to discontinue extracorporeal membrane oxygenation for postcardiotomy support. , 2001, The Annals of thoracic surgery.

[64]  P. Venge,et al.  Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study. , 1992, The Journal of thoracic and cardiovascular surgery.

[65]  P. Albertsson,et al.  Percutaneous coronary intervention facilitated by extracorporeal membrane oxygenation support in a patient with cardiogenic shock. , 2010, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[66]  J. Beca,et al.  Extracorporeal membrane oxygenation for treating severe cardiac and respiratory failure in adults: part 2-technical considerations. , 2010, Journal of cardiothoracic and vascular anesthesia.

[67]  D. S. Lawson,et al.  Hemolytic characteristics of three commercially available centrifugal blood pumps , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[68]  A. Pesenti,et al.  Adult Respiratory Distress Syndrome (Ards): Why Did Ecmo Fail? , 1981, The International journal of artificial organs.

[69]  T. Kickler,et al.  Effect of extracorporeal membrane oxygenation on platelets in newborns , 1993, Critical care medicine.

[70]  E. Fosse,et al.  Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems. , 1995, The Annals of thoracic surgery.

[71]  S. Thelin,et al.  Heparin-coated cardiopulmonary bypass circuits reduce blood cell trauma. Experiments in the pig. , 1991, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[72]  J. Shayevitz,et al.  The activated coagulation time: suitability for monitoring heparin effect and neutralization during pediatric cardiac surgery. , 1996, Journal of cardiothoracic and vascular anesthesia.

[73]  R. Bartlett,et al.  Use of venovenous extracorporeal membrane oxygenation and an atrial septostomy for pulmonary and right ventricular failure. , 2011, The Annals of thoracic surgery.

[74]  E. Fosse,et al.  Heparin-coated cardiopulmonary bypass equipment. I. Biocompatibility markers and development of complications in a high-risk population. , 1999, The Journal of thoracic and cardiovascular surgery.

[75]  Influence of oxygenator type on the prevalence and extent of microembolic retinal ischemia during cardiopulmonary bypass. Assessment by digital image analysis. , 1990 .

[76]  C. Coopersmith,et al.  Extracorporeal membrane oxygenation: current clinical practice, coding, and reimbursement. , 2008, Chest.

[77]  P. McCarthy,et al.  Extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock. , 1996, The Annals of thoracic surgery.

[78]  E. Farthmann,et al.  Extracorporeal membrane oxygenation: a ten-year experience. , 2000, American journal of surgery.

[79]  E. Fosse,et al.  Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. , 1994, The Annals of thoracic surgery.

[80]  F. Szlam,et al.  A Comparison of Heparin Management Strategies in Infants Undergoing Cardiopulmonary Bypass , 2008, Anesthesia and analgesia.

[81]  F. Colardyn,et al.  The use of the activated clotting time for monitoring heparin therapy in critically ill patients , 2003, Intensive Care Medicine.

[82]  Pascal Leprince,et al.  Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock* , 2008, Critical care medicine.

[83]  F. Pigula,et al.  Anticoagulation and pediatric extracorporeal membrane oxygenation: impact of activated clotting time and heparin dose on survival. , 2007, The Annals of thoracic surgery.

[84]  S. Allen,et al.  Cooling gradients and formation of gaseous microemboli with cardiopulmonary bypass: an echocardiographic study. , 1997, The Annals of thoracic surgery.

[85]  BM Leschinsky,et al.  Centrifugal blood pumps — a brief analysis: development of new designs , 1991, Perfusion.

[86]  A. Mazzucco,et al.  Heparin-coated circuits for high-risk patients: a multicenter, prospective, randomized trial. , 1999, The Annals of thoracic surgery.

[87]  S. Vesconi,et al.  TREATMENT OF ACUTE RESPIRATORY FAILURE WITH LOW-FREQUENCY POSITIVE-PRESSURE VENTILATION AND EXTRACORPOREAL REMOVAL OF CO2 , 1980, The Lancet.

[88]  W. Muntean,et al.  Coagulation and anticoagulation in extracorporeal membrane oxygenation. , 1999, Artificial organs.

[89]  W. S. Haworth The development of the modern oxygenator. , 2003, The Annals of thoracic surgery.

[90]  P. Mankad,et al.  Management of anticoagulation and its reversal during paediatric cardiopulmonary bypass: a review of current UK practice , 2000, Perfusion.

[91]  D. Elbourne,et al.  UK COLLABORATIVE RANDOMIZED TRIAL OF NEONATAL EXTRACORPOREAL MEMBRANE OXYGENATION , 1997 .

[92]  R. Bartlett,et al.  Extracorporeal life support. , 2006, Seminars in pediatric surgery.

[93]  K. Moser,et al.  Surgical management of chronic pulmonary embolism: surgical treatment and late results. , 1980, The Journal of thoracic and cardiovascular surgery.

[94]  B. Kiaii,et al.  Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. , 2004, The Annals of thoracic surgery.

[95]  N. Smedira,et al.  Risk factors for intracranial hemorrhage in adults on extracorporeal membrane oxygenation. , 1999, European Journal of Cardio-Thoracic Surgery.

[96]  C. Baufreton,et al.  Inflammatory response to cardiopulmonary bypass using roller or centrifugal pumps. , 1999, The Annals of thoracic surgery.

[97]  Dean F. Sittig,et al.  Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. , 1994, American journal of respiratory and critical care medicine.

[98]  E. Lehr,et al.  Peripheral versus central cannulation for extracorporeal membrane oxygenation: a comparison of limb ischemia and transfusion requirements. , 2010, The Thoracic and cardiovascular surgeon.

[99]  Shengshou Hu,et al.  Five-year results of 121 consecutive patients treated with extracorporeal membrane oxygenation at Fu Wai Hospital. , 2011, Artificial organs.

[100]  G. Schears,et al.  Optimal Time for Initiating Extracorporeal Membrane Oxygenation , 2009, Seminars in cardiothoracic and vascular anesthesia.

[101]  G. Magovern,et al.  Extracorporeal membrane oxygenation for adult cardiac support: the Allegheny experience. , 1999, The Annals of thoracic surgery.

[102]  W. Buhre,et al.  Successful use of a miniaturized bypass system with the DeltaStream extracorporeal rotary blood pump. , 2003, The Journal of thoracic and cardiovascular surgery.

[103]  R. Fumagalli,et al.  Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. , 1986, JAMA.

[104]  M. Ziegler,et al.  The significant relationship between platelet count and haemorrhagic complications on ECMO , 1994, Perfusion.

[105]  R. Hetzer,et al.  Prevalence and persistence of heparin/platelet factor 4 antibodies in patients with heparin coated and noncoated ventricular assist devices. , 2000, ASAIO journal.

[106]  C. Brizard,et al.  Pump-induced haemolysis: a comparison of short-term ventricular assist devices , 2004, Perfusion.

[107]  Diana Elbourne,et al.  Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial , 2009, The Lancet.